TPG Inc. (NASDAQ: TPG) — The Laggard Tier’s Best Fundraiser, Where the Cap Table Keeps the Change

Independent fundamental research Report date: 2026-06-13 · Price: $43.01 · Total equity value ~$16.5B · 52-wk range $36.95–$70.38

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information only — not investment advice. The analysis that follows takes no position and carries no price target; this opening block is the single place a view is expressed.

Verdict: HOLD — fairly valued for what it is. Accumulate only on deeper weakness toward the high-$30s. Medium conviction. Directional zone: At ~$43 TPG trades at roughly 16–17× trailing after-tax distributable earnings (~$2.55–2.60/unit) and ~12× forward — a clear premium to Carlyle’s ~11×, and mid-pack against Apollo/KKR (~15–16×). For a manager with best-in-tier fundraising momentum but the lowest FRE margin in the peer set (~45%), the thinnest carry cushion, and a structurally dilutive/leaky cap table, fair value is roughly 14–17× DE, i.e. ~$40–$50. The stock sits near the middle of that band and the bottom quartile of its own (short, post-2022-IPO) valuation history. I would accumulate below ~$38 (near the $36.95 52-week low, ~13× DE plus a ~5% yield), hold in the low-to-mid $40s, and trim into a re-rate through the mid-$50s.

The hardest fact about TPG is also the most encouraging one: its fundraising is genuinely excellent and getting better — flagship vintages closing ~12% larger than their predecessors, $51.5B raised in 2025 (+71% YoY) while industry PE fundraising fell 11%, and FRE compounding ~31% since the 2022 IPO. That is the opposite of Carlyle’s stalled flagship and, on its own, justifies some of TPG’s ~50% multiple premium to Carlyle. But the bull case leans almost entirely on that momentum, and three things temper it. First, the cap table keeps the change: ~59% of the economics sit in non-controlling operating units, total units grow ~3.4%/year from acquisition-funded compensatory grants and heavy stock comp (~$814M in 2025), and a Tax Receivable Agreement pays 85% of cash-tax savings to pre-IPO insiders — so per-unit DE grows materially slower than the headline FRE the bulls quote. Second, the quality metrics are bottom-of-class: the ~45% FRE margin is the lowest among the big-caps (vs. 57–69% at BX/APO/KKR), the 2026 guide to 47% leans on lumpy capital-markets/transaction fees, and the carry bank (~$1.3B, aging) is thin — making the model unusually fundraising-dependent. Third, the insider signal is a negative echo of Carlyle’s: zero open-market buying into a ~39% drawdown, the Bonderman estate liquidating ~$978M of stock in 2025, and $75M of fresh founder/CEO special awards granted into the weakness — versus KKR’s leadership investing ~$51M of their own cash.

Framing: quality-growth-at-a-fairer-price-than-before, not deep value. Unlike Carlyle (a deep-value “priced to fail” setup) or KKR (a mispriced #1), TPG is roughly fairly priced — you get a faster-growing franchise than Carlyle, but you pay a full tier more for it, and the dilution/leakage quietly offsets part of the growth edge.

Conviction: Medium. Flips bullish if the 47% FRE margin proves durable (not a transaction-fee spike), per-unit DE growth visibly outruns the ~3–4% dilution, and fundraising momentum holds through 2026–27 — at a lower entry. Flips bearish on a fundraising air-pocket (the model’s soft underbelly given thin carry), a credit-mark deterioration in the Angelo Gordon/Twin Brook book, or evidence the AI-exposed software PE portfolio (~18% of PE AUM) is impairing.

One-liner: Carlyle’s faster-growing cousin — better fundraising, same thin margins, and an Up-C cap table that skims the upside.

1. Executive Summary

TPG Inc. is a $306 billion global alternative asset manager built on private equity (Capital, Growth, Impact/Rise), with a large credit-and-real-estate arm acquired through the November-2023 purchase of Angelo Gordon, plus real estate and market-solutions platforms. It went public in January 2022 and is run by CEO Jon Winkelried (formerly co-COO of Goldman Sachs). It sits firmly inside the scaled-incumbent club of alternative managers, but at the smaller, tier-edge end (~$306B vs. $744B–$1.3T for KKR/Blackstone), and shares with Carlyle the profile of a sub-50%-FRE-margin, fundraising-dependent franchise rather than a best-in-class compounder.

The investment question is sharpened by comparison: Carlyle (CG) is TPG’s closest analog — same laggard-tier margin, same FRE-dominated/thin-carry model, same asset-light (no-captive-insurance) posture, same ex-Goldman-operator-as-CEO. The difference is price and momentum. The debate: does TPG’s ~50% multiple premium to Carlyle (~16× vs. ~11× DE) reflect genuine superiority, or is a Carlyle-quality franchise simply priced one tier too high?

The case for the premium (Facts). TPG’s fundraising is the best in the laggard tier and arguably competitive with anyone’s: flagship funds are closing ~12% larger than prior vintages, the firm raised a record $51.5B in 2025 (+71%) while the industry shrank, FRE has compounded ~31% since IPO and crossed $1B (LTM), and the Growth/Impact platforms plus the Angelo Gordon credit engine give real growth optionality. Its retail-credit book is far more redemption-insulated than the peers caught in the June-2026 wave (nontraded BDC TCAP is only ~$4.5B with ~1.3% redemption requests). And it is building durable new channels — private wealth (inflows +66% in 2025) and an asset-light insurance partnership with Jackson Financial.

The case against the premium (Facts). The ~45% FRE margin is the lowest in the big-cap set; the 2026 guide to 47% leans on high-margin but lumpy capital-markets/transaction fees, not durable management-fee economics. The carry bank (~$1.3B, concentrated in 2020-and-prior vintages) is thin, so the model is unusually dependent on continued fundraising rather than a deep reservoir of unrealized gains. The Up-C structure parks ~59% of economics in non-controlling interests; total units grew ~3.4% in 2025 from acquisition-funded compensatory grants and ~$814M of stock comp; and the Tax Receivable Agreement diverts 85% of cash-tax savings to pre-IPO owners — so Class A holders capture less of the growth than the headline numbers suggest. No insider bought a share into the drawdown; the Bonderman estate sold ~$978M.

Verdict of the body (no recommendation): TPG is a structurally good business with the best fundraising engine in its quality tier, inside a structurally good industry — but it is priced a full tier above its closest, lower-multiple analog, and the Up-C/TRA/dilution mechanics quietly tax the per-unit growth that justifies that premium. The “What Must Be True” falsification tests below — durable margin, per-unit DE outrunning dilution, and fundraising continuity — are the live determinants.

2. Business Overview

TPG, founded in 1992 by David Bonderman, James Coulter, and William Price and headquartered in Fort Worth, Texas, manages $306.2 billion of AUM and $175.4 billion of fee-earning AUM (FAUM) as of Q1-2026 (FY2025: $303.0B / $170.1B). Like all alternative managers, it earns recurring management fees on locked, long-dated capital, plus performance fees/carried interest on gains — but TPG is unusually fee-related-earnings-dominated: roughly 91% of distributable earnings come from fees, with realized carry a thin contributor. GAAP figures are distorted by the Up-C structure (most economics sit in non-controlling operating units), so the body uses TPG’s non-GAAP operating metrics, reconciled to the 10-K.

Platforms (FY2025 AUM / FAUM):

• Private Equity (Capital + Growth + Impact) is TPG’s heritage and identity — control and growth investing in technology, healthcare, consumer, and industrials. Software is ~18% of PE AUM (an AI-disruption focal point for analysts). The flagships are growing fund-over-fund — a genuine differentiator versus Carlyle’s stalled GPE.
• Credit (TPG Angelo Gordon) is now the largest platform, acquired in November 2023. It is overwhelmingly institutional drawdown capital — Twin Brook lower-middle-market direct lending, Credit Solutions, asset-based finance, structured credit — with only a small retail-NAV slice (the ~$4.5B TCAP nontraded BDC). This is the key reason TPG was largely spared the June-2026 retail-credit redemption wave.
• Real Estate management expects to enter “a major multiyear fundraising cycle” beginning in 2026, with most flagship RE capital closing in 2027.
• Market Solutions houses the capital-markets business (transaction/monitoring fees — high-margin but lumpy) and Peppertree (digital infrastructure / cell towers, acquired July 2025).

Revenue quality. The franchise is more annuity-like than its carry-light peers in one sense (fees are ~91% of DE) but less cushioned in another (the carry bank is thin, so there’s little stored, unrealized gain to harvest in a slow-fundraising year). Management fees grew from $1.18B (2023) to $1.80B (2025); fee-related revenues reached $2.11B in 2025.

Verdict: A genuine, diversified, multi-platform alternative manager whose center of gravity has shifted toward credit (via Angelo Gordon) while its PE flagships keep growing — a healthier growth profile than Carlyle’s, anchored by a thinner carry cushion and a more fundraising-dependent earnings model.

3. Industry Dynamics

The structural backdrop is common to the large alternative managers (Carlyle, Apollo, Blackstone, KKR, Blue Owl) and is summarized here as it bears on TPG.

Profit pool and structure. Alternative asset management is an attractive, consolidating, oligopolistic industry: long-dated locked capital generates high-margin recurring fees, barriers to entry at scale are very high, and limited partners are concentrating commitments into fewer, larger managers (“K-shaped”). TPG is inside the scaled club but at the smaller end — which cuts both ways: more room to grow share, but less of the scale advantage that drives peer margins.

Three secular tailwinds (Facts / Interpretation):

1. Rising institutional allocations to alternatives.
2. Retail / wealth & 401(k) penetration — a 2025 U.S. executive order easing private assets into defined-contribution plans is a multi-year tailwind. TPG’s private-wealth inflows rose ~66% in 2025 (+130% YoY in Q1-2026 off a small base); retail is <5% penetrated for the firm.
3. Insurance balance-sheet migration into private credit — the dominant growth vector for Apollo (Athene) and KKR (Global Atlantic). TPG has no captive insurer and pursues this asset-light, via the new Jackson Financial partnership (minimum $4B FAUM by year 2, $12B by year 5) and insurer SMAs.

Capital-cycle caution (Marathon lens — Interpretation). The private-credit sub-segment shows late-cycle signatures: capital roughly tripled in five years, spread/fee compression, the marketing frontier shifting to retail, record dry powder, and Fitch’s U.S. private-credit default rate hitting a record ~6.0% in April 2026. Most acutely, a June-2026 sector-wide retail private-credit redemption wave struck — Blackstone’s BCRED saw ~10% redemption requests (5% cap invoked), Blue Owl’s flagship interval fund was gated at ~40%, and the group de-rated sharply (BX −38%, KKR −37%, Blue Owl ~−two-thirds, Carlyle −22%). TPG fell ~39% off its 52-week high in sympathy. But the redemption wave barely touched TPG operationally: its nontraded BDC (TCAP, ~$4.5B) saw redemption requests of only ~1.3% of shares with positive net subscriptions — placing TPG firmly at the insulated end of the spectrum (with KKR/Apollo), not the reflexive end (Blue Owl). The forward risk is that TPG is adding redemption-prone retail vehicles (a 2027 multi-strategy credit interval fund, a nontraded REIT, the T-POP perpetual PE vehicle) as it scales wealth — raising exposure over time.

Regulatory backdrop. The 401(k) order is a tailwind. Insurance-flywheel scrutiny (Bermuda/Pillar-Two minimum tax — which cost Apollo a $1.7B DTA write-off in Q1-2026) largely bypasses TPG’s asset-light model.

Verdict: structurally good industry, mid-to-late cycle in private credit — with TPG positioned among the redemption-insulated names. The secular case favors scaled incumbents; the near-term capital-cycle risk is concentrated in retail credit, where TPG’s current exposure is low (though rising as it builds wealth distribution).

4. Competitive Position

Where is the moat, and what type? As across the sector, the durable advantages are (a) intangibles — track record, brand, LP trust; (b) economies of scale; and © customer captivity — locked, long-dated capital. TPG has all three, with a distinctive strength and a distinctive weakness.

• The strength — fundraising/franchise momentum. TPG’s clearest competitive evidence is that LPs are increasing their commitments: flagship vintages are closing ~12% larger than predecessors, and the firm raised a record $51.5B in 2025 (+71%) while industry PE fundraising fell 11%. This is the opposite of a brand in decline and is the single fact most supportive of a moat — LP captivity and brand pull are demonstrably intact and strengthening. The Growth and Impact (Rise) franchises are genuinely differentiated; the Rise climate/impact platform is a category leader.
• The weakness — scale-to-margin conversion. TPG’s ~45% FRE margin is the lowest in the big-cap peer set (Blackstone/Apollo ~57%, KKR ~69%). A genuine scale moat shows up as a superior margin; TPG’s sits at the bottom, evidence that at ~$306B it has not yet achieved peer-level operating leverage — partly because it is still integrating Angelo Gordon and reinvesting heavily (doubling the capital-markets team, building wealth distribution). The 2026 guide to 47% is progress but still trails badly, and leans on lumpy transaction fees.
• Customer captivity. The bulk of capital is locked drawdown-fund capital (sticky), and the credit book is institutional rather than redeemable-retail (a positive vs. the redemption-wave names). But TPG’s genuine perpetual capital is modest (T-POP ~$2.1B, TCAP, evergreen vehicles, REIT platforms) — it has no large permanent-capital base like KKR’s ~92% or Blue Owl’s ~85%.

Head-to-head. Against the peer set, TPG is mid-pack on quality and fundraising, bottom on margin and carry depth. Versus Carlyle specifically (the closest analog), TPG has the clearly better fundraising engine (growing flagships vs. stalled) but a thinner carry cushion (~$1.3B vs. Carlyle’s ~$2.6–2.9B), a more complex/leakier cap table (Up-C + TRA + dilution vs. Carlyle’s clean C-corp with buybacks), and a higher multiple. It lacks Carlyle’s AlpInvest secondaries franchise and any insurance book.

Does the moat tie to a financial outcome? Yes on the fundraising side — the franchise pull produces a fast-growing, recurring fee stream and high returns on the capital-light fee business. But the incomplete scale advantage is visible in the sector-low margin, and the per-unit economics are diluted by the cap-table mechanics. The moat is real (LPs keep showing up with more money) but the shareholder capture of that moat is partially leaked.

Verdict: a real, fundraising-driven moat, mid-tier in strength — with the franchise advantage partly offset at the per-share level by structural leakage. Not a crowded commodity manager; a genuine oligopolist with demonstrable LP pull, but one whose margin and cap-table convert that advantage into per-unit value less efficiently than the best peers.

5. Growth History and Forward Opportunities

History (Facts). Since the January-2022 IPO, TPG has roughly tripled AUM, expanded FRE margin ~800bp, and grown FRE at a ~31% CAGR. The recent multi-year trend:

The FY2024 margin dip to ~41.7% reflects the full-year Angelo Gordon cost base and integration; margin re-expanded to ~45% in 2025. The Angelo Gordon deal (Nov-2023) added ~$75B AUM and transformed TPG from a PE house into a PE-and-credit firm — credit is now the largest platform.

Quality-of-growth caveat (Interpretation). Headline growth is strong, but two factors mean per-unit shareholder growth is slower: (1) dilution — total economic units grew from ~365M (2024) to ~377M (2025) to ~384M (Q1-2026), ~3.4%/year, from acquisition-funded compensatory units (Angelo Gordon, Peppertree) and heavy SBC; and (2) the TRA diverts 85% of cash-tax savings to pre-IPO owners. So after-tax DE per unit (~$2.55–2.60) has grown more slowly than the ~31% FRE CAGR the bull case quotes.

Forward opportunities (Fact / management framing — treat as hypothesis):

• Flagship PE — TPG Capital X + Healthcare Partners III first close $10.1B (Q3-2025), with existing clients increasing commitments ~12% over the prior vintage; PE fundraising +80% in 2025 against an industry down 11%.
• Fundraising scale — record $51.5B raised in 2025 (+71%); management guides 2026 to exceed $50B and explicitly argues 2025 is “not a cyclical peak” but “a new level of expected annual fundraising with less volatility.”
• Real estate — “the beginning of a major multiyear fundraising cycle” (2026+), most flagship RE capital closing 2027.
• Private wealth — inflows +66% in 2025; T-POP guided to “more than double” in 2026; 40+ distribution platforms; <5% penetrated.
• Insurance — the Jackson Financial partnership (min $4B FAUM yr 2, $12B yr 5; TPG put $500M into Jackson common); insurance capital +50% in 2025 — asset-light, no captive.
• Inorganic — Angelo Gordon, Peppertree; management calls M&A “an arrow in our quiver” with “a lot of incoming,” interested in Europe, credit tuck-ins, infrastructure, and secondaries, but “picky.”

No explicit quantified multi-year target. Unlike Apollo’s and KKR’s published multi-year FRE/DE algorithms (or even Carlyle’s $1.9B-FRE/2028 target), TPG’s guidance is strictly one-year (47% FRE margin, >$50B raise in 2026). The growth story is pillar/narrative-based and softer on hard numbers — a modest negative for accountability.

Verdict: genuinely high-quality, best-in-tier gross growth, taxed into merely good per-unit growth. The fundraising engine is the best in the laggard tier and a real competitive asset; the dilution and TRA leakage mean shareholders capture less of it than the headlines imply.

6. Financial Quality

Earnings. FY2025 produced FRE of $952.6M (~45.2% margin), DE of $1,042.1M, and after-tax DE of $973.5M (~$2.55–2.60/unit), with fees ~91% of DE. Q1-2026 was strong: FRE $246.9M (+36% YoY), FRE margin 44.3% (+620bp YoY), after-tax DE $281.6M — a seasonally strong quarter. LTM FRE crossed $1B for the first time.

The margin question (the central QoE issue). The ~45% FRE margin is sector-low, and the 2026 guide to 47% is real but qualified: Q4-2025’s spike to a record 52% was driven by transaction/monitoring and capital-markets fees that management itself says carry “85–90% incremental contribution margin” — i.e., lumpy, high-margin fees that flatter the headline. The durable, management-fee-only margin is lower and should be discounted. Management has declined to commit to a path to 50% (“45% is a step along the way”). This is a manager still working toward, not yet at, peer-level profitability.

The carry bank (thin and aging). Net accrued performance was ~$1.28B at YE2025 (~$1.19B Q1-2026), concentrated in 2020-and-prior vintages ($809M). This is modest versus large peers and reinforces the FRE-dependent characterization: TPG has little stored unrealized gain to harvest, so a slow fundraising year would hit earnings harder than at a carry-rich peer. Recent realizations (One Oncology, Intersect Power) reportedly cleared at premiums to marks — a positive to validate against subsequent results. In Q1-2026, TPG cut PE portfolio marks ~1% to public-comp levels (TPG Capital −$2.4B multiple compression offset by +$1.2B earnings growth) — confirming marks track public markets with a lag.

Balance sheet. Reasonable but more levered than Carlyle: total debt ~$1.72B at YE2025 rising to ~$2.3B in Q1-2026 (after a $500M Jackson equity investment + new notes), against ~$826M cash — net debt ~$0.9–1.5B (~1× FRE). The debt is termed out (notes due 2031/2034/2036/2064; $1.75B revolver undrawn), and Fitch upgraded TPG to A- in 2025. Net interest expense roughly doubled to ~$74M. A Hudson Yards office build-out is a non-core expense drag through 2026.

Quality-of-earnings flags. (1) Heavy SBC — ~$814M added back to DE in 2025 (down from ~$1,006M) — non-cash but genuinely dilutive. (2) Compensatory M&A units (Angelo Gordon 43.8M + Peppertree units + earnouts) sit outside purchase price as post-combination comp — recurring dilution the deal headlines understate. (3) Rising goodwill/intangibles from Angelo Gordon (~$206M goodwill + ~$548M intangibles) and Peppertree (~$188M); ~$113M of acquired-intangible amortization added back to DE. (4) Growing TRA obligation (+$286M in 2025) — a real cash claim by insiders. (5) Negative GAAP book value (−$2.10/share) and tiny GAAP EPS — artifacts of the Up-C structure; use DE, not GAAP.

Verdict: sound, growing economics with a sector-low margin and a thin carry cushion, partially leaked by SBC, M&A-unit dilution, and the TRA. Cash generation is real and the dividend is funded, but the per-unit quality is a step below Carlyle’s (which buys back stock) and well below the high-margin peers.

7. Capital Allocation

Returns to shareholders. TPG pays a variable dividend equal to a percentage (~84–86%) of after-tax DE — recent quarterly declarations were $0.45 / $0.61 / $0.59, totaling ~$2.06 across the 2025 dividend year (vs. ~$1.74 in 2024), a ~4.8–5.4% yield at $43. There is no share buyback — and given that total units grow ~3.4%/year from M&A compensatory grants and SBC, the share count rises. This is a material contrast with Carlyle, which uses buybacks to keep its share count roughly flat. TPG returns most of its cash as dividends but does nothing to offset dilution.

M&A. TPG has been the most acquisitive of the laggard-tier managers: Angelo Gordon (credit/RE, Nov-2023, ~$1.14B GAAP purchase price; the ~$2.7B headline included ~52M compensatory units treated as post-combination comp), Peppertree (digital infrastructure/cell towers, July-2025, ~$390M GAAP + a $300M earnout + compensatory units; added ~$8B AUM), plus the Jackson Financial insurance partnership. The strategy is to buy growth and diversification — sensible in a consolidating industry — but funded substantially with equity units, which is why it is dilutive rather than accretive at the per-unit level.

Incentive alignment (mixed). Incentive comp ties to AUM, after-tax DE/share, FRE, FRE margin, and fund performance — a reasonable set, with prior special awards using stock-price hurdles. But two governance optics are negative: founder James Coulter received a $50M special award (July-2025) and CEO Winkelried a $25M special RSU award (Dec-2025) — both granted into the ~39% drawdown, a poor look. CEO 2025 pay was ~$29.9M (much of it carry/performance allocations).

Governance (a structural negative). TPG is a controlled company — exempt from the majority-independent-board requirement, and its board is not majority independent (9 management / 5 independent of 14). The dual-class structure gives Class B (operating units) 10 votes each; TPG GP A, LLC controls ~93.6% of the vote, held by Coulter and Winkelried. The “Sunset” to a majority-independent board and the end of controlled-company status is expected at the 2027 annual meeting — a defined but soft governance catalyst. The TRA pays pre-IPO owners and Angelo Gordon parties 85% of realized cash-tax savings.

Insider behavior (a negative tell). Zero open-market purchases by any insider into the ~39% drawdown — the same absent-conviction signal seen at Carlyle, and the opposite of KKR’s ~$51M of leadership buying. The Bonderman estate sold ~$978M of stock (May-2025) — an estate liquidation, not a conviction sell, but a real ~$1B overhang. Only trivial open-market sales otherwise.

Verdict: shareholder-friendly on dividends, shareholder-unfriendly on dilution and governance. Capital allocation funds a healthy ~5% dividend and buys sensible growth, but does nothing to offset structural dilution, diverts tax savings to insiders via the TRA, and operates under a controlled-company structure with no insider buying and ~$1B of recent insider selling. On a per-share basis, the capital-allocation grade is below Carlyle’s.

8. Changes and Headwinds — Last Two Years

Transformational credit acquisition (Fact). The November-2023 Angelo Gordon purchase reshaped TPG from a PE house into a diversified PE-and-credit manager; credit is now the largest platform (~$93B AUM). Integration is described as “hitting on every cylinder,” and it drove the FY2024 margin dip (now recovered). Peppertree (digital infrastructure, July-2025) extended TPG into towers/data-center adjacencies.

Strategic build-out (Fact / management framing). Under Winkelried, TPG has tripled AUM since IPO, pushed into private wealth (inflows +66% in 2025), launched an asset-light insurance strategy (Jackson partnership), built a firm-wide capital-markets business, and grown FRE ~31% annually. The thesis: scale existing and new strategies, integrate capital markets, drive operating leverage toward a 47%+ margin, and penetrate wealth and insurance.

Governance transitions (Fact). Co-founder David Bonderman died in December 2024; his ~20% control interest votes against all matters until a successor is named, and his estate sold ~$978M of stock in 2025. Several executives stepped off the board (Dec-2024); independent directors were added (Elsesser, Adm. McRaven). The controlled-company “Sunset” is expected at the 2027 annual meeting.

Headwinds (Facts):

• Sector de-rating — TPG fell ~39% off its high with the June-2026 retail-credit redemption wave, despite minimal operational exposure (TCAP redemptions ~1.3%).
• Sector-low FRE margin with a 47% guide that leans on lumpy transaction fees.
• AI disruption risk to the software-heavy PE book (~18% of PE AUM) — a recurring analyst concern; management points to a young (~3-year) book in vertical/embedded/cybersecurity software.
• Direct-lending mark-integrity skepticism — analysts repeatedly press on whether credit performance is sustainable.
• Dilution and TRA leakage as ongoing structural drags on per-unit value.
• Bonderman estate overhang and founder special awards into weakness.

Verdict: a fast-building, acquisitive franchise meeting a hostile tape and its own structural frictions. The strategic changes (credit diversification, wealth, insurance) strengthen the long-term thesis; the dilution, governance, and margin issues — plus a sector de-rating — temper it. On balance constructive but with more self-inflicted friction than the cleaner peers.

9. Risk Analysis

Overall risk verdict. TPG’s risks are to growth, margin, per-unit dilution, and multiple, not solvency. The asset-light, modestly-levered, diversified-fee model makes catastrophic loss very unlikely. The most distinctive risk is the combination of a thin carry cushion + high fundraising dependence + ongoing dilution: in a soft fundraising year, TPG has less to fall back on than a carry-rich peer, and the share count keeps rising regardless. The realistic bad outcome is multiple compression toward Carlyle’s tier as the growth premium fades, cushioned by a ~5% dividend.

10. Valuation Discussion (Embedded Expectations)

Where it trades. At $43.01, total equity value (Class A + operating units, ~384M units) is ~$16.5B. On the metrics that matter:

• P/after-tax-DE ≈ 16–17× trailing (~$2.55–2.60/unit), ~12× forward (reflecting expected growth)
• P/FRE ≈ 17× (~$953M FRE on $16.5B)
• Dividend yield ~4.8–5.4% (variable, ~84–86% of after-tax DE)
• AZI own-history valuation percentile: 28th composite (P/E 32nd, P/B 22nd, P/S 31st) — cheap relative to its own post-IPO range, though that history is only ~4 years of premium-multiple trading.

Peer comparison (the core of the valuation case):

The central valuation tension: TPG vs. Carlyle. TPG trades at ~16–17× DE versus Carlyle’s ~11× — a ~50% premium — for a franchise with the same sector-low margin and an even thinner carry cushion. What justifies the premium is fundraising momentum: TPG’s flagships are growing while Carlyle’s stalled, and TPG raised $51.5B (+71%) in 2025. That is a real and important difference and supports some premium. But two facts argue the premium is full, not cheap: (1) the per-unit growth that should earn the premium is diluted ~3.4%/year and taxed by the TRA, so Class A holders capture less of it; and (2) TPG’s 47% margin guide leans on lumpy transaction fees, so the quality gap to Carlyle is narrower than the headline FRE growth suggests. Net: TPG looks roughly fairly valued relative to Carlyle — you pay up for better growth, but the leakage offsets part of it.

Embedded-expectations analysis. At ~12× forward DE, the market is underwriting continued double-digit DE/unit growth — i.e., that fundraising momentum and margin expansion persist and outrun dilution. This is a more demanding embedded expectation than Carlyle’s (where the market prices failure). TPG is therefore the higher-beta bet within the pair: more upside if the growth proves durable (the multiple could hold or expand and DE compounds), but less margin of safety if fundraising stumbles — because the price already credits the momentum and the carry cushion is thin.

Scenario sketch (illustrative, not a target — no price target per firm policy):

• Bear: fundraising air-pocket, margin stalls at ~45%, dilution bites → DE/unit flat, multiple compresses toward Carlyle’s tier (~12×) → low-$30s, cushioned by ~5% yield.
• Base: momentum moderates but holds, DE/unit ~$2.80–3.20, ~14–15× → mid-$40s.
• Bull: fundraising stays hot, 47%+ margin sticks, DE/unit ~$3.50+, ~15–16× → high-$50s.

Verdict: roughly fairly valued — cheap on its own short history, mid-pack on quality, and at a justified-but-full premium to its closest analog. The margin of safety is thinner than Carlyle’s; the growth upside is greater. This is a fair-price-for-a-faster-grower, not a bargain.

11. Variant Perception

Consensus view. TPG is a fast-growing, post-IPO alternative manager that diversified smartly into credit (Angelo Gordon), is raising record capital, and got swept down ~39% with the private-credit redemption scare despite minimal exposure — a quality grower temporarily on sale.

Strongest bull case (variant). The market is conflating TPG with the redemption-wave names when its retail-credit exposure is tiny (TCAP redemptions ~1.3%) and its fundraising is the best in its tier — flagships growing ~12% per vintage, $51.5B raised in 2025 against a shrinking industry, FRE compounding ~31% since IPO. At ~28th percentile of its own history and a ~5% yield, you are buying a genuine share-gainer in a consolidating industry at the cheapest it has been since the IPO, with wealth, insurance (Jackson), and real estate (2026–27 cycle) as additional growth legs.

Strongest bear case (variant). TPG is a Carlyle-quality franchise (sector-low ~45% margin, thin/aging carry, fundraising-dependent) priced a full tier higher (~16× vs. ~11× DE), with structural leakage Carlyle lacks: ~59% of economics in NCI, ~3.4%/year dilution from M&A units and SBC, no buyback, and a TRA that diverts 85% of tax savings to insiders. The 47% margin guide leans on lumpy transaction fees; the software-heavy PE book faces AI risk; and the people who know it best aren’t buying — zero insider purchases, ~$978M of estate selling, and $75M of founder/CEO awards granted into the drawdown. Strip out the dilution and TRA, and the per-unit growth that justifies the premium shrinks.

The 3–5 assumptions that decide it:

1. Is the ~47% FRE margin durable (management-fee-driven), or a transaction-fee artifact?
2. Does per-unit DE growth visibly outrun the ~3–4% dilution?
3. Does fundraising momentum continue (the model’s load-bearing element given thin carry)?
4. Does the software PE book hold up against AI disruption?
5. Does the credit/direct-lending book maintain its marks through the cycle?

Falsifying evidence: Bull is falsified by a fundraising air-pocket, a margin reversion below 45%, or per-unit DE stagnating under dilution; bear is falsified by durable 47%+ margins, per-unit DE compounding double-digits net of dilution, and continued record fundraising — and, decisively, an insider open-market purchase.

Verdict: The variant perception worth holding is that TPG’s premium to Carlyle is justified but not generous — better growth, fairly priced, with the dilution/leakage as the under-appreciated offset. It is neither the bargain Carlyle is on price nor the mispriced #1 KKR is on quality; it is a fairly-valued faster-grower whose biggest risk is that the market is paying for momentum the cap table partly skims.

12. Fact vs. Interpretation

13. Open Questions

1. What is the durable, management-fee-only FRE margin (ex lumpy capital-markets/transaction fees)? The 47% guide’s quality hinges on this.
2. How fast does per-unit DE grow net of the ~3.4% dilution and the TRA leakage — is the per-share growth actually double-digit?
3. Does the Angelo Gordon/Twin Brook direct-lending book hold its marks through a rising-default cycle (Fitch ~6.0%)?
4. How exposed is the software PE book (~18% of PE AUM) to AI disruption, and are recent marks (One Oncology, Intersect Power exits “at premiums”) representative?
5. Why has no insider bought into a ~39% drawdown, while founders received $75M of fresh awards and the Bonderman estate sold ~$978M?
6. What is the genuine perpetual-capital base (T-POP, TCAP, evergreen, REITs) as a share of AUM, and how fast does redemption-prone retail grow as wealth scales (interval fund + REIT by 2027)?
7. Will the 2027 Sunset materially improve governance, or is the TRA/dual-class leakage permanent in economic substance?

14. What Must Be True

Bull case — what must be true:

• Fundraising momentum continues — flagships keep growing vintage-over-vintage, 2026 raise exceeds $50B, and real estate’s 2026–27 cycle delivers — sustaining the FRE growth the multiple credits.
• The ~47% FRE margin proves durable (management-fee-driven, not a transaction-fee spike) and progresses toward peer levels.
• Per-unit DE compounds double-digits net of dilution, so Class A holders actually capture the franchise growth.
• Falsification test: A fundraising shortfall (2026 raise materially below $50B) OR FRE margin reverting below 45% for two quarters falsifies the bull case — either would expose the model’s fundraising dependence and thin carry cushion, and the premium-to-Carlyle multiple would be unsupported.

Bear case — what must be true:

• The premium to Carlyle is unwarranted — TPG’s growth edge is offset by dilution, the TRA, and a margin that doesn’t durably exceed Carlyle’s, so per-unit value compounds only modestly.
• Fundraising decelerates or air-pockets, and with a thin carry bank, earnings prove more cyclical than the “new, less-volatile level” management claims.
• The software PE book and/or credit marks deteriorate, pressuring DE and realizations.
• Falsification test: Durable 47%+ margins, per-unit DE compounding double-digits net of dilution, and continued record fundraising — or an insider open-market purchase of size — falsifies the bear case. Any would confirm the growth premium is earned and the cap-table drag is tolerable.

As with Carlyle, both tests resolve on near-term, observable events — the 2026 fundraising number, the trajectory of the FRE margin, and per-unit DE net of dilution — so the reader will know within two or three quarters whether the premium is justified.

15. Source Appendix

See the Source Appendix (Appendix B below) for the full citation list. Primary sources: TPG FY2025 Form 10-K (filed 2026-02-17), Q1-2026 Form 10-Q (filed 2026-05-01), prior-year 10-Ks (FY2021–FY2024), 2026 DEF 14A proxy, the Form 4 insider corpus (2025–2026), the 8-K material-event record, and Q1-2026 / Q4-2025 / Q3-2025 earnings-call transcripts. Quantitative data: aggregated financial statements, ratios, enterprise value, and valuation multiples; own-history valuation percentiles; market price/market cap. Peer comparison data rests on the public filings of Carlyle, Apollo, Blackstone, KKR, and Blue Owl.

The analysis above carries no investment recommendation and no price target; the sole exception is the clearly-labeled Claude’s Take block at the top, which is the author’s own subjective view and general information, not investment advice.

APPENDIX A — Standard Diligence Questionnaire

TPG Inc. (NASDAQ: TPG) — as of 2026-06-13

Answers are labeled Fact / Interpretation / Assumption where it matters. Where a question does not map to an alternative asset manager, the correct sector analog is given.

General

What thoughtful questions have other investors asked about this company? From the 2025–2026 earnings calls, the recurring sell-side concerns are: (1) direct-lending/private-credit mark integrity and sustainability (Glenn Schorr/Evercore led three straight calls — “your stocks fall like rocks because people think… they don’t believe the performance will sustain”); (2) AI disruption of the software-heavy PE book (asked on every call — software ~18% of PE AUM); (3) the FRE-margin path to 50% (why only 47% given strong fundraising/transaction fees); (4) lumpiness of transaction/capital-markets fees and realization timing; (5) fundraising cadence (first/final-close elongation, RE 2026-vs-2027 timing). Interpretation: the market’s core worry is whether the growth/margin is durable and the credit marks are real — which the ~28th-percentile-of-own-history valuation reflects.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: fee earnings (FRE) are at a record and growing; realized carry is low (thin, aging carry bank ~$1.3B). Management argues 2025’s record fundraising is “not a cyclical peak” but “a new level” — a claim to treat skeptically given how fundraising-dependent the model is.

Driven by the external environment or internal actions? Largely internal — fundraising share gains, the Angelo Gordon acquisition, and capital-markets build-out drove FRE; external rates/exit markets affect the (small) carry component. Fact: PE fundraising +80% in 2025 while the industry fell 11% — internally-driven outperformance.

How stable are revenues? Management fees recur on locked capital (stable), but the model is fundraising-dependent with a thin carry cushion — less buffered than a carry-rich peer in a slow raise year. Capital-markets/transaction fees are lumpy.

Outlook / market size? Growing — rising institutional alts allocations, retail/wealth (401(k) order), insurance migration, and TPG’s own share gains. Global, multi-asset. Real estate entering a 2026–27 fundraising cycle.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Less competitive at the scaled top (consolidating, K-shaped); more competitive in commoditizing private-credit lending (spread compression, record dry powder, rising defaults — Fitch ~6.0%).

How profitable (ROIC, ROE)? High on the capital-light fee business, but the relevant metric is FRE margin (~45%) — the lowest in the big-cap peer set (BX/APO ~57%, KKR ~69%). GAAP ROE/book are distorted by the Up-C structure (negative GAAP book). Fact: sector-low margin is the defining quality weakness.

How profitable is the industry — barriers? Among the most profitable in financial services for scaled incumbents; very high barriers (track record, LP trust, scale). ~6–7 dominant global players; TPG is at the smaller end.

Can the business be easily understood? Moderately — the fee/carry model is simple, but the Up-C structure, NCI, TRA, and acquisition-unit accounting are complex. Assumption: a generalist must use DE/unit, not GAAP.

Undermined by foreign low-cost labor? No — relationship-, track-record-, and capital-driven.

Do brands matter? Yes — and TPG’s brand pull is strengthening (LPs increasing commitments ~12% per vintage). The Rise/Impact franchise is a category leader. This is TPG’s clearest moat evidence.

Nature of competition / switching costs? Competes on returns, track record, distribution, product breadth. LP capital is locked once committed (high switching costs), but each vintage must be re-won — and TPG is winning, unlike Carlyle.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The carry bank (~$1.3B net accrued performance) is a real economic asset; brand/track-record/LP relationships are unbooked. Caveat: the carry bank is thinner than peers’.

Off-balance-sheet liabilities? The TRA (85% of cash-tax savings owed to pre-IPO holders; +$286M liability in 2025) is a real, growing cash claim. Fund-level commitments funded over time. No insurance policyholder liabilities (asset-light; the Jackson partnership is a $500M equity stake, not consolidation).

How conservative is the accounting? Standard for the sector; use non-GAAP FRE/DE. Flags: heavy SBC (~$814M), compensatory M&A units treated as post-combination comp, rising goodwill/intangibles from Angelo Gordon/Peppertree.

How CapEx-hungry? Capital-light (fee manager); “investment” is GP fund commitments + the $500M Jackson stake + a Hudson Yards office build-out (non-core drag through 2026).

Capital Allocation & Management

How much FCF, and how is it used? After-tax DE ~$973.5M (FY2025, ~$2.55–2.60/unit). Used mostly for the variable dividend (~84–86% payout, ~5% yield); GP commitments; M&A (often equity-funded). Fact: no buyback — share count rises ~3.4%/year.

Significant acquisitions recently? Angelo Gordon (credit/RE, Nov-2023, ~$1.14B GAAP); Peppertree (digital infra, July-2025, ~$390M GAAP + $300M earnout); Jackson Financial insurance partnership. Interpretation: sensible diversification, but funded substantially with equity units — dilutive, not accretive per unit.

Buying back shares? No. Interpretation: a negative vs. Carlyle (which buys back to offset dilution).

Issuing large amounts of stock to insiders? Yes, structurally — M&A compensatory units + SBC + founder special awards ($50M Coulter July-2025; $25M Winkelried Dec-2025, granted into the drawdown). The Up-C means ~59% of economics sit in insider-held units.

Compensation / incentive metrics? Ties to AUM, after-tax DE/share, FRE, FRE margin, fund performance; prior special awards used stock-price hurdles. CEO 2025 pay ~$29.9M.

Motivations of management / insider behavior? Fact (negative tell): zero open-market insider purchases into the ~39% drawdown; Bonderman estate sold ~$978M (estate liquidation). Controlled company; GP LLC ~93.6% of vote (Coulter + Winkelried).

Valuation & Market Data

ADR, MLP, or K-1 issuer? TPG Inc. is a U.S. C-corporation (Class A common, 1099) with an Up-C structure — pre-IPO owners hold operating-group units (Class B, 10 votes, no economics) exchangeable into Class A. Not an ADR, MLP, or (for Class A holders) a K-1 issuer.

Dividend policy? Variable — ~84–86% of after-tax DE, paid quarterly (~$2.06 across the 2025 dividend year), ~5% yield. Contrasts with Carlyle’s fixed $1.40.

How profitable? Sector-low ~45% FRE margin; ~91% FRE-dominated DE.

Is net income diverging from cash from operations? GAAP net income is uninformative (Up-C/NCI noise; negative GAAP book). Use after-tax DE. Fact: ~59–61% of GAAP net income is attributed to NCI.

Risks & Downside

What would cause the stock to decline? A fundraising air-pocket; margin reversion below 45%; per-unit DE stagnating under dilution; credit-mark deterioration; AI impairment of software PE; multiple compression toward Carlyle’s tier.

Risk of catastrophic loss? Interpretation: low. Asset-light, ~1× net debt/FRE, diversified fees. The realistic bad outcome is multiple compression, not insolvency.

Chance of total loss? Interpretation: very low — a scaled, profitable, modestly-levered fee manager with a ~5% dividend.

Recent News & Events

Has the business environment changed recently? Yes — the June-2026 retail private-credit redemption wave de-rated the group and pulled TPG down ~39% off its high, despite TPG’s minimal operational exposure (TCAP redemptions ~1.3%). Fact: AZI flagged the June-4 sector sell-off (TPG/Ares/Artisan) as the notable negative item; an earlier Q1 review noted TPG led asset-management stocks on strong results.

Significant acquisitions / accounting changes / new markets? Angelo Gordon (credit, 2023); Peppertree (digital infra, 2025); the Jackson Financial insurance partnership (2026); the private-wealth and insurance build-outs; new debt issuance (2031/2036 notes). No accounting-policy changes of note beyond acquisition accounting.

Recent management/governance changes? Co-founder Bonderman died Dec-2024 (estate sold ~$978M); executives stepped off the board; independent directors added (Elsesser, Adm. McRaven); controlled-company “Sunset” expected at the 2027 annual meeting. Interpretation: a governance structure still in transition, with concentrated insider control until ~2027.

APPENDIX B — Source Appendix

TPG Inc. (NASDAQ: TPG) — Research as of 2026-06-13

Primary sources prioritized over secondary. Figures reconciled to filings where possible; ROIC.ai/AZI/yfinance are third-party aggregators used for convenience and cross-check, never as the authority over a filing.

Primary — SEC filings (EDGAR, CIK 0001880661; corpus mirrored locally to output/TPG/sources/)

1. Form 10-K, FY2025 — filed 2026-02-17. Segment/platform AUM/FAUM, management fees, FRE/FRE margin, distributable earnings, after-tax DE, carry bank (net accrued performance), share count (Class A + Common Units), dividend, debt, TRA, Angelo Gordon/Peppertree acquisition accounting. Source of record for operating metrics.
2. Form 10-Q, Q1 2026 — filed 2026-05-01. Q1-2026 AUM $306.2B / FAUM $175.4B, FRE $246.9M (44.3% margin), after-tax DE $281.6M, platform management fees, share count ~384M units, post-Jackson debt/cash.
3. Forms 10-K, FY2021–FY2024 — multi-year trend; the FY2024 10-K (filed 2025-02-18) is the source for FY2023; the FY2024 margin dip to ~41.7% (Angelo Gordon integration).
4. DEF 14A (2026 proxy) — controlled-company status; dual-class (Class B 10 votes; GP LLC ~93.6% of vote); CEO Winkelried comp (~$29.9M 2025); incentive metrics (AUM, after-tax DE/share, FRE, FRE margin, fund performance); TRA (85% of cash-tax savings); founder/executive ownership; Sunset expected 2027 AGM.
5. Form 4 insider corpus (2025–2026) — ~100 filings parsed; transaction-code tally (A/Deriv-A grants, F tax-withholding, G gifts, only 5 trivial S sales, P=0); the Bonderman estate ~$978M Class A sale (2025-05-22) + 2.9M-share resale shelf takedown.
6. 8-K corpus (2024–2026) — debt issuance (2034/2036/2064/2031 notes), board changes (Bonderman death Dec-2024; Elsesser, Adm. McRaven added), Coulter $50M (July-2025) and Winkelried $25M (Dec-2025) special awards, revolver upsizing, dividend declarations.

Primary — Earnings-call transcripts (ROIC.ai)

7. Q1 2026 call (2026-05-01) — CEO Winkelried, CFO Weingart, President Sisitsky. FRE margin 44.3% (+620bp); LTM FRE >$1B; 47% 2026 margin guide; >$50B fundraising guide; TCAP redemptions ~1.3%; PE marks cut ~1% to public comps.
8. Q4 2025 call (2026-02-05) — FY2025 results; record $51.5B raised (+71%); flagships +12% per vintage; “not a cyclical peak”; Q4 margin spike to 52% on capital-markets fees (85–90% incremental margin).
9. Q3 2025 call (2025-11-04) — TPG Capital X/HP III first close $10.1B; Jackson insurance dialogue; Peppertree integration; “45% is a step along the way.”

Quantitative aggregators (cross-check, reconciled to filings)

10. ROIC.ai MCP — income statement, balance sheet, enterprise value, valuation multiples, company profile, transcript bodies.
11. AZI valuation-percentile index (scripts/azi.sh fundamentals TPG) — own-history percentiles: composite 28th, P/E 32nd, P/B 22nd, P/S 31st (cheap vs its ~4-year post-IPO range; GAAP P/E distorted by Up-C). AZI news: June-4 sector sell-off (TPG/Ares/Artisan, negative); Q1 earnings-review (TPG led asset managers).
12. yfinance (scripts/fetch.py) — price $43.01, total equity value ~$16.5B, 52-wk range $36.95–$70.38, dividend yield ~5.2%, forward P/E ~12×.

Peer comparison (public filings)

13. Public filings and earnings reports of Carlyle (CG), Apollo (APO), Blackstone (BX), KKR, and Blue Owl (OWL) — used for peer FRE-margin, perpetual-mix, multiple, dividend, own-history-percentile, and verdict comparisons, and for shared industry framing (private-credit capital cycle, June-2026 retail redemption wave, FRE re-rating thesis). Carlyle is the primary analog.

Industry / sector context

14. Fitch U.S. private-credit default rate ~6.0% (record, April 2026) — capital-cycle indicator (via peer-report industry framing).
15. 2025 U.S. executive order easing private assets into 401(k)/defined-contribution plans — retail-channel tailwind (via peer-report industry framing).

Notes on data quality

• GAAP net income / book value are not used for valuation; they are distorted by the Up-C/NCI structure (negative GAAP book; ~59–61% of net income to NCI). Use after-tax DE per economic unit (~$2.55–2.60 FY2025).
• Total economic units (~377M FY2025, ~384M Q1-2026 = Class A + Common Units) are the correct per-share denominator, not Class A alone (~153–160M).
• Angelo Gordon GAAP purchase price was ~$1.14B (the ~$2.7B headline included compensatory units treated as post-combination comp); Peppertree GAAP price ~$390M (the ~$660M headline included earnout + compensatory units). Proficy/TCS HyperVault are fund-level investments, not TPG Inc. balance-sheet M&A.
• The “47% FRE margin” 2026 guide leans on lumpy, high-incremental-margin capital-markets/transaction fees; the durable management-fee-only margin is lower.
• Peer multiples are approximate, drawn from public filings of varying June-2026 dates; directional comparators, not precise same-day figures.